In the rapidly evolving landscape of behavioral health, a new and unsettling phenomenon has emerged, one that threatens the stability of addiction treatment centers and the quality of patient care. While the public has become increasingly aware of "AI psychosis" at the user level—where individuals develop harmful obsessions with chatbots—a more insidious version of the condition is taking root at the executive level. This "corporate AI psychosis" is characterized by a delusional belief in the transformative power of artificial intelligence, often in total defiance of operational reality and clinical necessity.
n
As the addiction treatment industry grapples with an unprecedented overdose crisis and shifting regulatory landscapes, the rush to integrate AI is being viewed by many veterans not as a breakthrough, but as a systemic failure of leadership.
n
Main Facts: The Dual Nature of AI Psychosis
n
To understand the current crisis in addiction treatment management, one must first distinguish between the two primary forms of AI-related psychological and organizational dysfunction.
n
The first form, widely documented in clinical literature, involves the end-user. This manifests as an addiction to AI chatbots, where the positive reinforcement loops built into Large Language Models (LLMs) lead to social isolation, distorted reality, and in extreme cases, self-harm or criminal activity. For these individuals, the chatbot becomes a surrogate for human interaction, reinforcing existing psychoses or creating new ones through "hallucinations" that the user accepts as absolute truth.
n
The second form, which is currently sweeping through the boardrooms of healthcare organizations, is what digital rights activist and author Cory Doctorow calls "investor and boss delusion." This is not a clinical diagnosis of the individual, but a functional psychosis of the organization. It involves a collective belief that AI will generate massive profits, eliminate the need for human labor, or "supercharge" productivity, despite a lack of empirical evidence that the technology can navigate the complexities of healthcare.
n
In the addiction treatment sector, this manifests as a "top-down" imposition of technology. Executives, spurred on by high-priced consultants, are demanding AI integration as a prerequisite for funding and "modernization," often at the expense of the human-centric programs that have been proven to save lives.
n
Chronology: From Innovation to Institutional Delusion
n
The trajectory of AI adoption in the behavioral health sector has moved through several distinct phases over the last decade, leading to the current state of "psychosis."
n
2020–2022: The Pandemic-Driven Digitization
n
The COVID-19 pandemic forced a rapid pivot to telehealth. During this period, the addiction treatment industry realized that digital tools could expand reach. However, the focus remained on human-to-human interaction facilitated by screens. The success of this era planted the seeds for the belief that technology could replace traditional brick-and-mortar limitations.
n
2023–2024: The Generative AI Boom
n
The release of ChatGPT and subsequent LLMs sparked a global gold rush. In the addiction treatment space, venture capital began flowing toward startups promising "AI therapists" or "automated intake systems." This period saw the rise of "investor delusion," where the mere mention of AI in a pitch deck could inflate a company’s valuation by millions, regardless of the product’s clinical validity.
n
2025–2026: The Era of Forced Integration
n
By 2026, the hype cycle reached a fever pitch. As noted in recent industry reports, a "drive" emerged where organizations felt they must have AI to remain competitive. This is the stage where "boss delusion" took hold. Management began viewing AI not as a tool to assist staff, but as a means to circumvent the ongoing labor shortage in behavioral health. It is within this timeframe that the "BHB Confessions" emerged, highlighting the disconnect between executive mandates and frontline reality.
n
Supporting Data: The Infrastructure Gap and the Silo Problem
n
The primary argument against the current "AI-first" mandate in addiction treatment is the fundamental lack of data infrastructure required for AI to function effectively. For an AI to provide meaningful insights in a healthcare setting, it requires access to clean, integrated, and longitudinal data. Currently, the industry suffers from three major "silos" that render AI largely ineffective.
n
1. The Insurance Data Silo
n
Health insurers utilize AI extensively to manage their risk and determine coverage. However, these companies are notoriously protective of their proprietary data. They do not share their predictive models or outcomes data with healthcare providers or government agencies. Consequently, a treatment center’s AI is often "hallucinating" conclusions based on incomplete datasets because it cannot see the full financial or medical history of the patient.
n
2. The Clinical Silo
n
Electronic Health Records (EHRs) in the behavioral health space are often fragmented. A patient may receive detox at one facility, residential treatment at another, and outpatient therapy at a third. Without a unified data exchange, an AI system at any single facility is working with a tiny fraction of the patient’s clinical picture.
n
3. The Budgetary Silo
n
A critical point raised by industry insiders is the "Fixed Budget Fallacy." In nonprofit addiction treatment, every dollar is typically earmarked for specific services—beds, counseling, medications, and food. AI advocates often claim that the technology will create "efficiencies" that free up capital. However, the initial cost of implementing AI, combined with the lack of immediate ROI, often results in "corporate self-harm," where funds are diverted from patient care to pay for software licenses and consultants.
n
Official Responses: The "BHB Confessions" and Industry Pushback
n
The most poignant critique of the current trend comes from those who have spent decades at the helm of these organizations. In a recent "BHB Confession" published by Better Health Business, a retired CEO with 50 years of experience in behavioral health expressed deep concern over the industry’s direction.
n
"What I have seen that troubles me is all of a sudden, there’s this drive that you have to have AI," the retired executive stated. "You have to have it if you don’t have it."
n
The executive noted that this drive is largely fueled by consultants who do not understand the day-to-day realities of addiction recovery. According to the CEO, the industry is "recycling solutions" that have failed in the past, merely wrapping them in the new "AI" label. The consensus among many veteran leaders is that the most effective solutions in addiction treatment have always been "bottom-up"—driven by the needs of the patients and the expertise of the clinicians—rather than "top-down" mandates from executives looking to satisfy investors.
n
Cory Doctorow’s analysis in Pluralistic supports this view, suggesting that the "psychosis" is a byproduct of a bubble. When executives believe that a technology must work because they have invested so much in the idea of it, they become blind to the operational friction it creates. This leads to a degradation of service quality as human staff are stretched thin, tasked with managing failing automated systems rather than treating patients.
n
Implications: The Human Cost of Corporate Delusion
n
The implications of AI psychosis in the addiction treatment industry are far-reaching and potentially life-threatening.
1. The Erosion of the Therapeutic Alliance
Addiction recovery is fundamentally built on the "therapeutic alliance"—the trust and connection between a patient and a human provider. When AI is used to automate intake, assessment, or even parts of therapy, that human connection is severed. For a population already prone to isolation and mistrust of institutions, the "cold" interface of an AI can be a barrier to seeking help.
2. Financial Destabilization
As organizations chase the AI dream, they risk financial ruin. The high cost of "exceptionalism"—the belief that one’s organization will be the one to finally make AI work—can drain the reserves of even the largest nonprofit systems. If the promised efficiencies do not materialize, the result is often staff layoffs and reduced bed capacity.
3. Policy and Governance Failures
When governments make policy based on the "possibilities" of AI rather than the reality of current treatment outcomes, they risk misallocating public health funds. If the "paper of record" for the industry is reporting that executives feel pressured to adopt technology they don’t believe in, it suggests a massive disconnect between policy-making and ground-level execution.
4. The Need for "Bottom-Up" Innovation
The path forward requires a rejection of the "top-down" AI mandate. True innovation in addiction treatment will likely come from using technology to support, rather than replace, human intervention. This includes tools that reduce the administrative burden on counselors—allowing them more face-to-face time with patients—rather than "boss-delusion" projects aimed at replacing counselors with algorithms.
Conclusion
The "AI psychosis" currently affecting the management of addiction treatment is a cautionary tale of what happens when technological hype outpaces clinical wisdom. While AI holds potential for the future of medicine, its current application in behavioral health is being driven more by a delusional fear of being left behind than by a desire to improve patient outcomes.
As the retired CEO told Better Health Business, the focus must return to the people using the services. The industry must prioritize the "passionate projects" funded by human empathy and clinical experience over the "efficient" projects promised by a silicon-based dream. In the world of addiction recovery, there is no substitute for human presence; to believe otherwise is the ultimate delusion.
If you or someone you know is struggling with thoughts of self-harm or suicide, please contact the Crisis and Suicide Lifeline by calling or texting 988, or visit 988lifeline.org.
